Leishmaniasis is a serious parasitic disease caused by Leishmania spp. transmitted through sandfly bites. This disease is a major public health concern worldwide. It can occur in 3 different clinical forms: cutaneous, mucocutaneous, and visceral Leishmaniasis (CL, MCL, and VL, respectively), caused by different Leishmania spp. Currently, licensed vaccines are unavailable for the treatment of human Leishmaniasis. The treatment and prevention of this disease rely mainly on chemotherapeutics, which are highly toxic and have an increasing resistance problem. The development of a safe, effective, and affordable vaccine for all forms of vector-borne disease is urgently needed to block transmission of the parasite between the host and vector. Immunological mechanisms in the pathogenesis of Leishmaniasis are complex. IL-12-driven Th1-type immune response plays a crucial role in host protection. The essential purpose of vaccination is to establish a protective immune response. To date, numerous vaccine studies have been conducted using live/attenuated/killed parasites, fractionated parasites, subunits, recombinant or DNA technology, delivery systems, and chimeric peptides. Most of these studies were limited to animals. In addition, standardization has not been achieved in these studies due to the differences in the virulence dynamics of the Leishmania spp. and the feasibility of the adjuvants. More studies are needed to develop a safe and effective vaccine, which is the most promising approach against Leishmania infection.
Citations
Citations to this article as recorded by
Identification of novel anti‐leishmanials targeting glutathione synthetase of the parasite: a drug repurposing approach Manash Sarma, Kushal Bora, Preeti Ranjan, Vikash Kumar Dubey FEBS Letters.2025; 599(3): 367. CrossRef
Molecular Mechanisms of Cell Death in Leishmania donovani Induced by Selected Steroidal Alkaloids Naveena Menpadi, Pranjal Chandra, Vikash Kumar Dubey Journal of Basic Microbiology.2025;[Epub] CrossRef
Key Facets for the Elimination of Vector-Borne Diseases Filariasis, Leishmaniasis, and Malaria Rini Chaturvedi, Amit Sharma ACS Infectious Diseases.2025; 11(2): 287. CrossRef
Human migrations, anthropogenic changes, and insect-borne diseases in Latin America André B. B. Wilke, Priscilla Farina, Marco Ajelli, Angelo Canale, Filipe Dantas-Torres, Domenico Otranto, Giovanni Benelli Parasites & Vectors.2025;[Epub] CrossRef
Vaccines in Dermatology—Present and Future: A Review Eyan Goh, Jean-Marc Chavatte, Raymond T. P. Lin, Lisa F. P. Ng, Laurent Rénia, Hazel H. Oon Vaccines.2025; 13(2): 125. CrossRef
Structure‐based Virtual Screening and Drug Design Development of Leishmanicidal Pyrimidines Gerliny Bezerra de Oliveira, Érick Caique Santos Costa, Zenaide Severina do Monte, Gleybson Correia de Almeida, Emerson Peter da Silva Falcão, Luciana Scotti, Marcus Tullius Scotti, Ricardo Oliveira Silva, Daniele Santana de Sousa Oliveira, Policarpo Adem Chemistry & Biodiversity.2025;[Epub] CrossRef
Attitudes and acceptance of vaccination against neglected tropical diseases: A multi-country study in Asia Li Ping Wong, Hai Yen Lee, Haridah Alias, Farhana Nishat Seheli, Abhishek Lachyan, Di Khanh Nguyen, Jamil Ahmed, Zhijian Hu, Yulan Lin Human Vaccines & Immunotherapeutics.2025;[Epub] CrossRef
Vaccine Designing Technology against Leishmaniasis: Current Challenges and Implication Jyoti Gupta, Yukta Menon, Subodh Kumar, Chakresh Kumar Jain Current Drug Discovery Technologies.2025;[Epub] CrossRef
Cutaneous Leishmaniasis in the Context of Global Travel, Migration, Refugee Populations, and Humanitarian Crises Janice Kim, Tarek Zieneldien, Sophia Ma, Bernard A. Cohen Clinics and Practice.2025; 15(4): 77. CrossRef
Histone Deacetylase Inhibitors Show a Potential Leishmanicidal Effect against Leishmania braziliensis in a Mouse Infection Model and Lead to Less Toxicity than Glucantime Luciana Ângelo de Souza, Lethícia Kelly Ramos Andrade, Joice de Melo Agripino, Victor Hugo Ferraz da Silva, Sabrina de Oliveira Emerick, Adriana Carneiro da Silva, Larissa Coelho Pereira, Graziela Domingues de Almeida Lima, Ingrid Rabite Garcia, Anna Cláu ACS Omega.2025; 10(19): 19466. CrossRef
Computational vaccine development against protozoa Omar Hashim, Isabelle Dimier-Poisson Computational and Structural Biotechnology Journal.2025; 27: 2386. CrossRef
Control measures for neglected tropical diseases: vaccine updates Vivek P. Chavda, Suneetha Vuppu, Toshika Mishra, Nikita Sharma, Sathvika Kamaraj, Shatakshi Mishra, Bhumi Sureshbhai, John Matsoukas, Vasso Apostolopoulos Expert Review of Vaccines.2025; 24(1): 535. CrossRef
Attitudes and acceptance of mRNA-based vaccine for neglected tropical diseases: A multi-country study in Asia Li Ping Wong, Hai Yen Lee, Haridah Alias, Di Khanh Nguyen, Abhishek Lachyan, Farhana Nishat Seheli, Jamil Ahmed, Zhijian Hu, Yulan Lin Human Vaccines & Immunotherapeutics.2025;[Epub] CrossRef
Development of vaccines against Leishmania mexicana: a reverse vaccinology approach Isis Pérez-Concepción, Iván Corona Guerrero, Angela Corina Hayano Kanashiro, Nohemí Gámez Meza, Armando Tejeda-Mansir Biotecnia.2025; 27: e2537. CrossRef
A Human Monoclonal Antibody Targeting α-Gal Ameliorates Experimental Cutaneous Leishmaniasis Hyeseon Cho, Andrea Paun, Youngsil Seo, Sang Hun Lee, Maria Traver, Ming Zhao, Jeff Skinner, Joshua Tan, David L Sacks, Peter D Crompton The Journal of Infectious Diseases.2025;[Epub] CrossRef
Advances in recombinant protein vaccines against Leishmania infantum: a systematic review of vaccinal constructs and delivery strategies André Zaidan Martins, Ana Laura Grossi de Oliveira, Lilian Lacerda Bueno, Fabrício Marcus Silva Oliveira, Ricardo Toshio Fujiwara Acta Tropica.2025; 270: 107796. CrossRef
The impact of probiotic administration in vivo on peritoneal mouse macrophages infected by Leishmania amazonensis ex vivo Lauren Van den Broeck, Raquel Silva de Azevedo, Ludmila Ferreira de Almeida Fiuza, Marcos Meuser Batista, Cynthia Machado Cascabulho, Ewout Van de Velde, Serge Van Calenbergh, Guy Caljon, Maria de Nazaré Correia Soeiro Memórias do Instituto Oswaldo Cruz.2025;[Epub] CrossRef
In silico design and assessment of a multiepitope and multiantigen potential vaccine candidate against Leishmania donovani Satabdi Saha, Sahina Laskar, Seshan Gunalan, Gugan Kothandan, Diwakar Kumar In Silico Pharmacology.2025;[Epub] CrossRef
Understanding Sex-biases in Kinetoplastid Infections: Leishmaniasis and Trypanosomiasis Olivia Battistoni, Ryan H. Huston, Chaitenya Verma, Thalia Pacheco-Fernandez, Sara Abul-Khoudoud, Alison Campbell, Abhay R. Satoskar Expert Reviews in Molecular Medicine.2025;[Epub] CrossRef
Luring the vector: A systematic review of sand fly attractants Panagiota Tsafrakidou, Arsen Gkektsian, Michael Miaoulis, Lee W. Cohnstaedt, Alexandra Chaskopoulou Current Research in Parasitology & Vector-Borne Diseases.2025; 8: 100325. CrossRef
Intracellular Parasitic Infections Caused by Plasmodium falciparum, Leishmania spp., Toxoplasma gondii, Echinococcus multilocularis, Among Key Pathogens: Global Burden, Transmission Dynamics, and Vaccine Advances—A Narrative Review with Contextual Insight Tatevik Sargsyan, Lala Stepanyan, Avetis Tsaturyan, Rosanna Palumbo, Caterina Vicidomini, Giovanni N. Roviello Vaccines.2025; 13(11): 1082. CrossRef
Repurposing Acetylcholinesterase Inhibitors for Leishmaniasis: Donepezil Hydrochloride and Related Compounds Against the American Tegumentary Form Daniela E. Barraza, Emilse N. Araoz, María A. Occhionero, Daniela A. Gaspar, Eliana G. Guevara, María E. Vázquez, Brenda A. Zabala, Paola A. Barroso, Cecilia Pérez Brandán, Carlos J. Minahk, Leonardo Acuña Antibiotics.2025; 14(12): 1182. CrossRef
Genetic Manipulation Tools in Leishmania: From CRISPR/Cas9 to Vaccine Strategies for Disease Control Merve Gundogdu, Zeynep Islek Acta Parasitologica.2025;[Epub] CrossRef
CRISPR-Cas13b mediated gene knockdowns in Leishmania infantum Marine Queffeulou, Raouia Fakhfakh, Fereshteh Fani, Alex Dos Santos, Gabriel Reis Ferreira, Sophia Bigot, Chantal Godin, Philippe Leprohon, Barbara Papadopoulou, Marc Ouellette International Journal for Parasitology: Drugs and Drug Resistance.2025; : 100629. CrossRef
Memory T cells: promising biomarkers for evaluating protection and vaccine efficacy against leishmaniasis Mahmoud Nateghi-Rostami, Yahya Sohrabi Frontiers in Immunology.2024;[Epub] CrossRef
GSK-3 kinase a putative therapeutic target in trypanosomatid parasites Alfredo Prado Diaz, Cristian Alejandro Meneses Canal, Alvaro José Valdés, Jaider Elian Giraldo Delgado, RE Varela-M The Brazilian Journal of Infectious Diseases.2024; 28(2): 103736. CrossRef
Live attenuated-nonpathogenic Leishmania and DNA structures as promising vaccine platforms against leishmaniasis: innovations can make waves Negar Seyed, Tahereh Taheri, Sima Rafati Frontiers in Microbiology.2024;[Epub] CrossRef
Dual Antitubercular and Antileishmanial Profiles of Quinoxaline Di-N-Oxides Containing an Amino Acidic Side Chain Juan F. González, María-Auxiliadora Dea-Ayuela, Lena Huck, José María Orduña, Francisco Bolás-Fernández, Elena de la Cuesta, Nazia Haseen, Ashraf Ali Mohammed, J. Carlos Menéndez Pharmaceuticals.2024; 17(4): 487. CrossRef
The role of CD4+ T cells in visceral leishmaniasis; new and emerging roles for NKG7 and TGFβ Jinrui Na, Christian Engwerda Frontiers in Cellular and Infection Microbiology.2024;[Epub] CrossRef
Pilot-Scale Screening of Clinically Approved Drugs to Identify Uridine Insertion/Deletion RNA Editing Inhibitors in Trypanosoma brucei Mojtaba Rostamighadi, Arezou Kamelshahroudi, Vanessa Pitsitikas, Kenneth A. Jacobson, Reza Salavati ACS Infectious Diseases.2024; 10(9): 3289. CrossRef
Effect of Leishmania infantum infection on B cell lymphopoiesis and memory in the bone marrow and spleen Laura Dirkx, Marlotte Loyens, Sara I. Van Acker, Dimitri Bulté, Mathieu Claes, Magdalena Radwanska, Stefan Magez, Guy Caljon The FASEB Journal.2024;[Epub] CrossRef
In silico and in vitro evaluation of the immunogenic potential of Leishmania donovani ascorbate peroxidase and its derived peptides Shobha Kumari, Saravanan Vijaykumar, Vikash Kumar, Ravi Ranjan, Dayakar Alti, Veer Singh, Ghufran Ahmed, Ganesh Chandra Sahoo, Krishna Pandey, Ashish Kumar Acta Tropica.2024; 260: 107381. CrossRef
The Major Role of T Regulatory Cells in the Efficiency of Vaccination in General and Immunocompromised Populations: A Review Stanislaw Stepkowski, Dulat Bekbolsynov, Jared Oenick, Surina Brar, Beata Mierzejewska, Michael A. Rees, Obi Ekwenna Vaccines.2024; 12(9): 992. CrossRef
Prospects and Challenges of Genetically Modified Live-Attenuated Leishmania Vaccines Suman Karmakar, Mousumi Das, Monalisa Ray, Soumyadip Mukherjee, Sanhita Ghosh, Kamalika Roy, Chiranjib Pal Zoonoses.2024;[Epub] CrossRef
A review of leishmaniasis: current knowledge and future directions of heterocyclic molecules Tejaswini Masne, Dileep Kumar, Deepali Bansode Exploration of Drug Science.2024; : 508. CrossRef
A squalene oil emulsified MPL-A and anti-CD200/CD300a antibodies adjuvanted whole-killed Leishmania vaccine provides durable immunity against L. donovani parasites Baishakhi Mahapatra, Abhishek Singh, Arpita Banerjee, Shruti Sirohi, Samer Singh, Vikash K. Dubey, Rakesh K. Singh Vaccine.2024; 42(26): 126373. CrossRef
C57BL/6 Peritoneal Macrophage Exosomes Improve Antileishmanial Functions of the RAW264.7 Cells Hadis Gandomkar, Mostafa Changaei, Mir Mohammadreza Hosseini, Sara Soudi, Ahmad Zavaran Hosseini Parasite Immunology.2024;[Epub] CrossRef
India should invest in the expansion of genomic epidemiology for vector-borne diseases filariasis, malaria and visceral leishmaniasis that are targeted for elimination Nandini Singh, Amit Sharma IJID Regions.2024; 13: 100453. CrossRef
Advances in Leishmania Vaccines: Current Development and Future Prospects Andreina Ayala, Alejandro Llanes, Ricardo Lleonart, Carlos M. Restrepo Pathogens.2024; 13(9): 812. CrossRef
Development and application of species ID and insecticide resistance assays, for monitoring sand fly Leishmania vectors in the Mediterranean basin and in the Middle East Sofia Balaska, Jahangir Khajehali, Konstantinos Mavridis, Mustafa Akiner, Kyriaki Maria Papapostolou, Latifa Remadi, Ilias Kioulos, Michail Miaoulis, Emmanouil Alexandros Fotakis, Alexandra Chaskopoulou, John Vontas, Yara M. Traub-Csekö PLOS Neglected Tropical Diseases.2024; 18(12): e0012408. CrossRef
A Review of the Progress in the Development of Leishmaniasis Vaccines Narges Khaghanzadeh, Fatemeh Javadi, Afshin Samiei Journal of Ardabil University of Medical Sciences.2024; 24(2): 129. CrossRef
A minor emphasis on the outbreak of cutaneous leishmaniasis after devastating earthquakes in Turkey Ilknur Nihal Ardic, Nurittin Ardic Asian Pacific Journal of Tropical Medicine.2023; 16(3): 97. CrossRef
Immunotherapy and immunochemotherapy in combating visceral leishmaniasis Ganesh Yadagiri, Aakriti Singh, Kanika Arora, Shyam Lal Mudavath Frontiers in Medicine.2023;[Epub] CrossRef
Efficacy of an Immunotherapy Combining Immunogenic Chimeric Protein Plus Adjuvant and Amphotericin B against Murine Visceral Leishmaniasis Danniele L. Vale, Camila S. Freitas, Vívian T. Martins, Gabriel J. L. Moreira, Amanda S. Machado, Fernanda F. Ramos, Isabela A. G. Pereira, Raquel S. Bandeira, Marcelo M. de Jesus, Grasiele S. V. Tavares, Fernanda Ludolf, Miguel A. Chávez-Fumagalli, Alexs Biology.2023; 12(6): 851. CrossRef
Evaluation of murine OX40L-murine IgG1(MM1) fusion protein on immunogenicity against L. mexicana infection in BALB/c mice Hossein Rezvan, Selman A. Ali, Sahar Hamoon Navard, Robert Rees Comparative Immunology, Microbiology and Infectious Diseases.2023; 99: 102011. CrossRef
Leishmania infection upregulates and engages host macrophage Argonaute 1, and system-wide proteomics reveals Argonaute 1-dependent host response Atieh Moradimotlagh, Stella Chen, Sara Koohbor, Kyung-Mee Moon, Leonard J. Foster, Neil Reiner, Devki Nandan Frontiers in Immunology.2023;[Epub] CrossRef
Recent Patents in the Treatment and Prevention of Leishmaniasis Sukhbir K Shahid Pharmaceutical Patent Analyst.2023; 12(5): 237. CrossRef
First
Prev
